Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Ganmiao New Material Technology is a chemical enterprise based in Shijiazhuang, China, that specializes in the research, development, and distribution of pharmaceutical intermediates and fine chemicals. The company provides a broad range of organic compounds and specialty materials used as building blocks for the synthesis of active pharmaceutical ingredients (APIs). Serving a global clientele, they operate primarily through B2B channels to supply the biotech and pharmaceutical industries with high-purity research chemicals. Their business model focuses on chemical manufacturing and international trade of new material technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Ganmiao New Material Technology.